期刊文献+

塞来昔布对卵巢癌细胞SKOV3生长与侵袭能力的抑制效应 被引量:1

Inhibitory effect of celecoxib on proliferation,invasion and VEGF expression of ovarian carcinoma SKOV3 cells
下载PDF
导出
摘要 目的:探讨环氧化酶-2(COX-2)选择性抑制剂塞来昔布(celecoxib)对卵巢癌细胞增殖、侵袭能力、血管内皮生长因子(VEGF)表达的影响。方法:SKOV3细胞经塞来昔布处理后,以MTT比色法测定各组细胞增殖水平,以细胞侵袭实验检测细胞侵袭转移能力,RT-PCR及ELISA检测SKOV3细胞VEGF mRNA及蛋白的表达水平。结果:与对照未加药组相比,不同浓度塞来昔布可有效抑制SKOV3细胞的增殖与侵袭能力,同时显著下调细胞VEGF在mRNA及蛋白水平的表达水平。上述效应均呈明显剂量效应关系,组间差异均有统计学意义(P<0.05)。结论:塞来昔布对卵巢癌SKOV3细胞的增殖、侵袭能力及VEGF表达均有明显的抑制作用。 Objective:To investigate the effects of cyclooxygenase-2(COX-2) inhibitor celecoxib on proliferation,invasion,VEGF expression in nasopharyngeal carcinoma SKOV3 cells.Methods:SKOV3 cells were treated with celecoxib at various concentrations.MTT assay and invasion assay were performed to observe the inhibitory activity of celecoxib on SKOV3 cells,and VEGF expression was analyzed by RT-PCR and ELISA.Results:Treatment of celecoxib significantly suppressed the capacity of proliferation,invasion and down-regulated the VEGF mRNA and protein expression of SKOV3 cells,in a dose-dependent manner(P0.05).Conclusion:Celecoxib has a significant inhibitory activity on cell proliferation,invasion and VEGF expression in ovarian carcinoma SKOV3 cells.These findings implicate that application of celecoxib may be an effective strategy for the therapy of ovarian carcinoma.
出处 《现代肿瘤医学》 CAS 2013年第7期1474-1477,共4页 Journal of Modern Oncology
关键词 塞来昔布 卵巢癌 增殖 侵袭 血管内皮生长因子 celecoxib ovarian carcinoma cell proliferation tumor invasion VEGF
  • 相关文献

参考文献12

  • 1CeccareUi F, Barberi S, Pontesilli A, et al. Ovarian carcinoma pres- enting with axiUary lymph node metastasis: a case report[ J ]. Eur J Gynaecol Oncol, 2011,32 ( 2 ) : 237 - 239.
  • 2Ozuysal S, Bilgin T, Ozgur T, et al. Expression of cyclooxygenase - 2 in ovarian serous carcinoma:correlation with angiogenesis, rim23 expression and survival [ J ]. Eur J Gynaeeol Oncol,2009,30 (6): 640 - 645.
  • 3Becket MR, Siegelin MD, Rompel R, et al. COX- 2 expression in malignant melanoma: a novel prognostic marker [ J ] .Melanoma Res,2009,19( 1 ) :8 -16.
  • 4Lev - Ari S, Lichtenberg D, Arber N. Compositions for treatment of cancer and inflammation[ J ]. Recent Pat Anticancer Drug Discov, 2008,3( 1 ) :55 -62.
  • 5王菊勇,郭净,郑展.iNOS/COX-2与恶性肿瘤[J].现代肿瘤医学,2012,20(1):183-186. 被引量:16
  • 6Greenhough A, Smartt HJ, Moore AE, et al. The COX -2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumor microenvironment [ J ]. Carcinogenesis, 2009,30 ( 3 ) : 377 - 386.
  • 7Noda M,Tatsumi Y,Tomizawa M, et al. Effects of etodolac, a selec- tive cyclooxygenase- 2 inhibitor, on the expression of E -cadherin - catenin complexes in gastrointestinal cell lines [ J ]. J Gastmen- terol,2002,37 ( 11 ) : 896 - 904.
  • 8Kim TJ, Lee YS, Kang JH, et al. Prognostic significance of expres- sion of VEGF and COX - 2 in nasopharyngeal carcinoma and its as- sociation with expression of C - erbB2 and EGFR [ J ]. J Surg On- col,2011,103( 1 ) :46 -52.
  • 9Queiroga FL,Pires I, Parente M, et al. COX -2 over- expression correlates with VEGF and tumour angiogenesis in canine mammary cancer[ J ]. Vet J ,2011 , 189 ( 1 ) :77 - 82.
  • 10Kunnumakkara AB, Diagaradjane P, Anand P, et al. Curcumin sensitizes human eolorectal cancer to capecitabine by modulation of cyclin DI ,COX - 2, MMP - 9, VEGF and CXCR4 expression in an orthotopic mouse model[ J ].Int J Cancer, 2009,125 (9) : 2187 - 2197.

二级参考文献54

  • 1Levon BF, Celina T, Fujiyama O, et al. Canonical and noncanonical Wnt pathway: A comparison among normal ovary, benign ovarian tumor and ovarian cancer[ J ]. Oncol Rep, 2009,21:313 -320.
  • 2Wenyan L, Heather NT, Adam K, et al. Suppression of Wnt/β - catenin signaling inhibits prostate eaneer cell proliferation[ J ]. Eur J Pharmaceol,2009.602:8 - 14.
  • 3Josbert JK, Johan AO, Paul D,et al. Molecular analysis of sulindae -resistant adenomas in familial adenomatous polyposis [ J ]. Clin Cancer Res ,2001,7:4000 - 4007.
  • 4EMJ Boon, JJ Keller, TAM Wormhoudt, et al. Sulindac targets nuclear β - catenin accumulation and Wnt signaling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines [ J ]. Br J Cancer, 2004,90:224 -229.
  • 5金正均.合并用药中的相加作用.中国药理学报,1980,1:70-73.
  • 6Yang F, Zeng Q, Yu G, et al. Wnt/beta -catenin signaling inhibits death receptor - mediated apoptosis and promotes invasive growth of NSCLC [ J ]. Cell Signal,2006,18:679 - 687.
  • 7Ria Sayat, Brian Leber. O - GIcNAc - glycosylation of β - catenin regulates its nuclear localization and transcriptional activity [J ]. Exp Cell Res,2008,314:2774 -2787.
  • 8Han L, Li L, Mary LD, et al. Pro - apoptotic actions of cxisulind and CP461 in SW480 colon tumor cells involveβ - catenin and cyclinD1 down- regulation [ J ]. Biocheal Pharmacol, 2002, 64: 1325 - 1336.
  • 9Frank TK. ITF- 2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with β - eatenin defects and promotes neoplastic transformation [ J ]. Cancer Cell, 2002,2 : 145 - 155.
  • 10Hong Y, Yang JW, Wu WB , et al, Knockdown of BCL2LI2 leads to cisplatin resistance in MDA - MB - 231 breast cancer cells[ J]. Biochimica et Biophysica Acta, 2008,1782:649 - 657.

共引文献18

同被引文献8

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部